Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Effect of treatment for 12 weeks with rilapladib, a lipoprotein-associated phospholipase A2 inhibitor, on arterial inflammation as assessed with 18F-fluorodeoxyglucose-positron emission tomography imaging.

Tawakol A, Singh P, Rudd JH, Soffer J, Cai G, Vucic E, Brannan SP, Tarka EA, Shaddinger BC, Sarov-Blat L, Matthews P, Subramanian S, Farkouh M, Fayad ZA.

J Am Coll Cardiol. 2014 Jan 7-14;63(1):86-8. doi: 10.1016/j.jacc.2013.07.050. Epub 2013 Aug 21. No abstract available.

2.

Effect of long-term homocysteine reduction with B vitamins on arterial wall inflammation assessed by fluorodeoxyglucose positron emission tomography: a randomised double-blind, placebo-controlled trial.

Potter K, Lenzo N, Eikelboom JW, Arnolda LF, Beer C, Hankey GJ.

Cerebrovasc Dis. 2009;27(3):259-65. doi: 10.1159/000199463. Epub 2009 Feb 6.

PMID:
19202330
3.

Imaging of arterial inflammation: keeping our cool on a hot topic.

Tsao CW, Vasan RS.

JACC Cardiovasc Imaging. 2013 Dec;6(12):1260-2. doi: 10.1016/j.jcmg.2013.09.010. No abstract available.

4.

Vascular inflammation stratified by C-reactive protein and low-density lipoprotein cholesterol levels: analysis with 18F-FDG PET.

Yoo HJ, Kim S, Park MS, Yang SJ, Kim TN, Seo JA, Kim SG, Kim NH, Seo HS, Baik SH, Choi DS, Choi KM.

J Nucl Med. 2011 Jan;52(1):10-7. doi: 10.2967/jnumed.110.080838. Epub 2010 Dec 13.

5.

Pulmonary artery aneurysm due to systemic vasculitis: assessment of vascular inflammation using F-18 FDG positron emission tomography.

Ha JW, Lee JD, Kim YJ, Yun MJ, Chung N.

Eur Heart J. 2007 Apr;28(7):779. No abstract available.

PMID:
17431001
6.
7.

(18)F-FDG PET/CT for diagnosis and treatment response evaluation in large vessel vasculitis.

Karunanithi S, Sharma P, Bal C, Kumar R.

Eur J Nucl Med Mol Imaging. 2014 Mar;41(3):586-7. doi: 10.1007/s00259-013-2591-8. Epub 2013 Nov 6. No abstract available.

PMID:
24196914
8.

Pre-pulseless Takayasu's arteritis evaluated with 18F-FDG positron emission tomography and gadolinium-enhanced magnetic resonance angiography.

Meave A, Soto ME, Reyes PA, Cruz P, Talayero JA, Sierra C, Alexanderson E.

Tex Heart Inst J. 2007;34(4):466-9.

9.

[Vasculitis assessment with [18F]FDG positron emission tomography].

Liozon E, Monteil J, Ly KH, Vidal E.

Rev Med Interne. 2010 Jun;31(6):417-27. doi: 10.1016/j.revmed.2009.06.011. Epub 2010 Apr 22. French.

PMID:
20416990
10.

[Large vessel vasculitis diagnosed by positron emission tomography/computed tomography presenting with non-specific symptoms].

Andersen KF, Skøt J, Bülow J, Suetta C.

Ugeskr Laeger. 2012 May 7;174(19):1313-4. Danish.

PMID:
22564691
11.

The prevalence of inflammation in carotid atherosclerosis: analysis with fluorodeoxyglucose-positron emission tomography.

Tahara N, Kai H, Nakaura H, Mizoguchi M, Ishibashi M, Kaida H, Baba K, Hayabuchi N, Imaizumi T.

Eur Heart J. 2007 Sep;28(18):2243-8. Epub 2007 Aug 5.

PMID:
17681956
12.

Disposition and metabolism of darapladib, a lipoprotein-associated phospholipase A2 inhibitor, in humans.

Dave M, Nash M, Young GC, Ellens H, Magee MH, Roberts AD, Taylor MA, Greenhill RW, Boyle GW.

Drug Metab Dispos. 2014 Mar;42(3):415-30. doi: 10.1124/dmd.113.054486. Epub 2013 Dec 30.

13.

Imaging atherosclerotic burden and inflammation: insights into the spectrum of atherosclerotic disease in HIV.

Tawakol A, Grinspoon SK.

J Nucl Cardiol. 2015 Apr;22(2):381-4. doi: 10.1007/s12350-014-0044-9. Epub 2014 Dec 24. No abstract available.

PMID:
25537613
14.

Splenic metabolic activity predicts risk of future cardiovascular events: demonstration of a cardiosplenic axis in humans.

Emami H, Singh P, MacNabb M, Vucic E, Lavender Z, Rudd JH, Fayad ZA, Lehrer-Graiwer J, Korsgren M, Figueroa AL, Fredrickson J, Rubin B, Hoffmann U, Truong QA, Min JK, Baruch A, Nasir K, Nahrendorf M, Tawakol A.

JACC Cardiovasc Imaging. 2015 Feb;8(2):121-30. doi: 10.1016/j.jcmg.2014.10.009. Epub 2015 Jan 7.

15.

18F-fluorodeoxyglucose-positron emission tomography imaging in idiopathic inflammatory myositis.

Harari OA, Al-Nahhas A, Jawad A.

Nucl Med Commun. 2008 Sep;29(9):838-40. doi: 10.1097/MNM.0b013e328304e0fa. No abstract available.

PMID:
18677214
16.

Concurrent chemo-radiotherapy potentiates vascular inflammation: increased FDG uptake in head and neck cancer patients.

Wang YC, Hsieh TC, Chen SW, Yen KY, Kao CH, Chang KC.

JACC Cardiovasc Imaging. 2013 Apr;6(4):512-4. doi: 10.1016/j.jcmg.2012.06.017. No abstract available.

17.

Positron emission tomography in the diagnosis of giant cell arteritis.

Fletcher TM, Espinola D.

Clin Nucl Med. 2004 Oct;29(10):617-9.

PMID:
15365432
18.

Do we need 18F-FDG-positron emission tomography as a functional imaging technique for diagnosing large vessel arteritis?

Wenger M, Calamia KT, Salvarani C, Moncayo R, Schirmer M.

Clin Exp Rheumatol. 2003 Nov-Dec;21(6 Suppl 32):S1-2. Review. No abstract available.

PMID:
14740421
19.

Diagnosis of incidental thyroid nodules on 18F-fluorodeoxyglucose positron emission tomography imaging: are these significant?

Sharma SD, Jacques T, Smith S, Watters G.

J Laryngol Otol. 2015 Jan;129(1):53-6. doi: 10.1017/S0022215114003107. Epub 2014 Dec 15.

PMID:
25496842
20.

Atherosclerosis inflammation imaging with 18F-FDG PET: carotid, iliac, and femoral uptake reproducibility, quantification methods, and recommendations.

Rudd JH, Myers KS, Bansilal S, Machac J, Pinto CA, Tong C, Rafique A, Hargeaves R, Farkouh M, Fuster V, Fayad ZA.

J Nucl Med. 2008 Jun;49(6):871-8. doi: 10.2967/jnumed.107.050294. Epub 2008 May 15.

Supplemental Content

Support Center